190 related articles for article (PubMed ID: 34571986)
1. The Platelet-Activating Factor Receptor's Association with the Outcome of Ovarian Cancer Patients and Its Experimental Inhibition by Rupatadine.
Deuster E; Hysenaj I; Kahaly M; Schmoeckel E; Mayr D; Beyer S; Kolben T; Hester A; Kraus F; Chelariu-Raicu A; Burges A; Mahner S; Jeschke U; Trillsch F; Czogalla B
Cells; 2021 Sep; 10(9):. PubMed ID: 34571986
[TBL] [Abstract][Full Text] [Related]
2. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Hong S; Jiang W; Xu C
J Hematol Oncol; 2014 May; 7():39. PubMed ID: 24886678
[TBL] [Abstract][Full Text] [Related]
4. Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancer.
Aponte M; Jiang W; Lakkis M; Li MJ; Edwards D; Albitar L; Vitonis A; Mok SC; Cramer DW; Ye B
Cancer Res; 2008 Jul; 68(14):5839-48. PubMed ID: 18632638
[TBL] [Abstract][Full Text] [Related]
5. Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Zhu Z; Jiang W; Xu C
J Exp Clin Cancer Res; 2014 Sep; 33(1):85. PubMed ID: 25261977
[TBL] [Abstract][Full Text] [Related]
6. Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epithelium.
Zhang L; Wang D; Jiang W; Edwards D; Qiu W; Barroilhet LM; Rho JH; Jin L; Seethappan V; Vitonis A; Wang J; Mok SC; Crum C; Cramer DW; Ye B
Reprod Biol Endocrinol; 2010 Jun; 8():74. PubMed ID: 20576130
[TBL] [Abstract][Full Text] [Related]
7. The expression of platelet-activating factor receptor modulates the cisplatin sensitivity of ovarian cancer cells: a novel target for combination therapy.
Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Zhang M; Jiang W; Xu C
Br J Cancer; 2014 Jul; 111(3):515-24. PubMed ID: 24921917
[TBL] [Abstract][Full Text] [Related]
8. Role of the platelet-activating factor and its receptor in the proliferative regulation of bovine ovarian granulosa cells.
Viergutz T; Löhrke B
Cell Prolif; 2007 Dec; 40(6):949-60. PubMed ID: 18021181
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor induces platelet-activating factor production through receptors transactivation and cytosolic phospholipase A2 in ovarian cancer cells.
Yu Y; Zhang X; Hong S; Zhang M; Cai Q; Jiang W; Xu C
J Ovarian Res; 2014; 7():39. PubMed ID: 24721622
[TBL] [Abstract][Full Text] [Related]
10. Effects of Rupatadine on Platelet- Activating Factor-Induced Human Mast Cell Degranulation Compared With Desloratadine and Levocetirizine (The MASPAF Study).
Munoz-Cano R; Ainsua-Enrich E; Torres-Atencio I; Martin M; Sánchez-Lopez J; Bartra J; Picado C; Mullol J; Valero A
J Investig Allergol Clin Immunol; 2017; 27(3):161-168. PubMed ID: 27758758
[TBL] [Abstract][Full Text] [Related]
11. Rupatadine protects against pulmonary fibrosis by attenuating PAF-mediated senescence in rodents.
Lv XX; Wang XX; Li K; Wang ZY; Li Z; Lv Q; Fu XM; Hu ZW
PLoS One; 2013; 8(7):e68631. PubMed ID: 23869224
[TBL] [Abstract][Full Text] [Related]
12. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro].
Jiang W; Wang YS; Cong Q; Li MJ; Ye B; Xu CJ
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):931-5. PubMed ID: 22333285
[TBL] [Abstract][Full Text] [Related]
13. RGS4 inhibits platelet-activating factor receptor phosphorylation and cellular responses.
Richardson RM; Marjoram RJ; Barr AJ; Snyderman R
Biochemistry; 2001 Mar; 40(12):3583-8. PubMed ID: 11297424
[TBL] [Abstract][Full Text] [Related]
14. Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells.
Bae R; Arteaga A; Raj JU; Ibe BO
Int Arch Allergy Immunol; 2012; 158(1):18-26. PubMed ID: 22212397
[TBL] [Abstract][Full Text] [Related]
15. Role of PAF receptors during intestinal ischemia and reperfusion injury. A comparative study between PAF receptor-deficient mice and PAF receptor antagonist treatment.
Souza DG; Pinho V; Soares AC; Shimizu T; Ishii S; Teixeira MM
Br J Pharmacol; 2003 Jun; 139(4):733-40. PubMed ID: 12812996
[TBL] [Abstract][Full Text] [Related]
16. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
Ryan SD; Harris CS; Mo F; Lee H; Hou ST; Bazan NG; Haddad PS; Arnason JT; Bennett SA
J Neurochem; 2007 Oct; 103(1):88-97. PubMed ID: 17877634
[TBL] [Abstract][Full Text] [Related]
17. Janus kinase 2 activation by the platelet-activating factor receptor (PAFR): roles of Tyk2 and PAFR C terminus.
Lukashova V; Chen Z; Duhé RJ; Rola-Pleszczynski M; Stanková J
J Immunol; 2003 Oct; 171(7):3794-800. PubMed ID: 14500680
[TBL] [Abstract][Full Text] [Related]
18. Platelet-Activating Factor-Receptor Signaling Mediates Targeted Therapies-Induced Microvesicle Particles Release in Lung Cancer Cells.
Chauhan SJ; Thyagarajan A; Chen Y; Travers JB; Sahu RP
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198218
[TBL] [Abstract][Full Text] [Related]
19. Loss of the platelet activating factor receptor in mice augments PMA-induced inflammation and cutaneous chemical carcinogenesis.
Sahu RP; Kozman AA; Yao Y; DaSilva SC; Rezania S; Martel KC; Warren SJ; Travers JB; Konger RL
Carcinogenesis; 2012 Mar; 33(3):694-701. PubMed ID: 22223848
[TBL] [Abstract][Full Text] [Related]
20. Platelet-Activating Factor Deteriorates Lysophosphatidylcholine-Induced Demyelination Via Its Receptor-Dependent and -Independent Effects.
Tian Z; Chu T; Shields LBE; Zhu Q; Zhang YP; Kong M; Barnes GN; Wang Y; Shields CB; Cai J
Mol Neurobiol; 2020 Oct; 57(10):4069-4081. PubMed ID: 32661728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
